[Central nervous system relapses in acute lymphoblastic leukemia and different methods of prophylaxis]. 1995

L Kachel, and E Rudzka, and S Krzemień, and M Krawczyk, and J Wojnar, and J Hołowiecki
Kliniki Hematologii Slaskiej A.M. w Katowicach.

The results of two different methods of CNS prophylaxis during consolidation were evaluated among fifty one acute lymphoblastic leukemia patients (ALL) treated in 1980-1991 in the Department of Hematology in Katowice. In group I (n = 28) methotrexate (Mtx) was used intrathecally (it) in 6 doses of 18 mg, in group II high dose cytosine arabinoside (Hi AraC)--3g/m2 intravenously (4x) was used with CNS rtg--therapy (18-24Gy). In both groups frequency of CNS relapses was similar 17.8% vs 17.3%; additionally there were no statistically significant differences in RFS: 369 vs. 562 days. The survival of patients with and without CNS relapses was also similar (678 vs. 774 days) and was independent of prophylaxis. The tolerance of both the used methods of CNS prophylaxis was good.

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L Kachel, and E Rudzka, and S Krzemień, and M Krawczyk, and J Wojnar, and J Hołowiecki
December 1989, Blood,
L Kachel, and E Rudzka, and S Krzemień, and M Krawczyk, and J Wojnar, and J Hołowiecki
January 1986, Neurotoxicology,
L Kachel, and E Rudzka, and S Krzemień, and M Krawczyk, and J Wojnar, and J Hołowiecki
January 2006, Hematology. American Society of Hematology. Education Program,
L Kachel, and E Rudzka, and S Krzemień, and M Krawczyk, and J Wojnar, and J Hołowiecki
November 1989, Cancer,
L Kachel, and E Rudzka, and S Krzemień, and M Krawczyk, and J Wojnar, and J Hołowiecki
October 1988, Anales espanoles de pediatria,
L Kachel, and E Rudzka, and S Krzemień, and M Krawczyk, and J Wojnar, and J Hołowiecki
November 2015, Pediatric blood & cancer,
L Kachel, and E Rudzka, and S Krzemień, and M Krawczyk, and J Wojnar, and J Hołowiecki
February 1980, Blood,
L Kachel, and E Rudzka, and S Krzemień, and M Krawczyk, and J Wojnar, and J Hołowiecki
May 2010, Cancer,
L Kachel, and E Rudzka, and S Krzemień, and M Krawczyk, and J Wojnar, and J Hołowiecki
January 2014, Mediterranean journal of hematology and infectious diseases,
L Kachel, and E Rudzka, and S Krzemień, and M Krawczyk, and J Wojnar, and J Hołowiecki
January 2019, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!